Stock CALADRIUS BIOSCIENCES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MarketScreener Strategies Caladrius Biosciences Inc Nasdaq

Equities

US1280581042

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Caladrius Biosciences Inc
Apr. 23 Lisata Therapeutics, Qilu Pharmaceutical Dose First Patient in China Trial of LSTA1 Plus Chemo for Pancreatic Cancer MT
Apr. 23 Lisata Therapeutics, Inc and Qilu Pharmaceutical Co., Ltd Announce First Patient Treated in Qilu?s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LSTA Stock
  4. Stock
  5. News Caladrius Biosciences Inc
  6. MarketScreener Strategies